Thomas Stephen
Components Development Laboratory, NHS Blood and Transplant, Brentwood, Essex, UK.
Transfus Med. 2010 Dec;20(6):361-8. doi: 10.1111/j.1365-3148.2010.01025.x.
Blood services routinely separate whole blood into components that are then stored under different conditions. The storage conditions used for whole blood prior to separation must therefore be a compromise between the needs of the red cells (which benefit from refrigeration) and plasma and platelets (which are better preserved at ambient temperature). For many years, the approach has been to manufacture plasma and platelet components on the day of blood collection, and to refrigerate any unprocessed blood for manufacture into red cell components on the following day. However, this can make it challenging to maintain adequate stocks of all components. The European practice of 'ambient hold' of whole blood for up to 24 hours prior to processing allows greater flexibility in blood component manufacture, and the data reviewed suggest there is relatively little impact on the quality of red cell or plasma components, and an improvement in the quality of platelet components.
血液服务机构通常会将全血分离成不同成分,然后在不同条件下储存。因此,分离前全血的储存条件必须在红细胞(冷藏有益)与血浆和血小板(在常温下保存更佳)的需求之间进行折衷。多年来,一直采用的方法是在采血当天制备血浆和血小板成分,将未处理的血液冷藏,以便次日制成红细胞成分。然而,这可能会使维持所有成分的充足库存变得具有挑战性。欧洲在处理前将全血“常温保存”长达24小时的做法,在血液成分制备方面具有更大的灵活性,且所审查的数据表明,这对红细胞或血浆成分的质量影响相对较小,同时血小板成分的质量有所提高。